Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
Leading Cystic Fibrosis Therapeutics Country Markets Databank
... 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $3,196.0 Million in 2020, and is anticipated to reach $4,216.6 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific and ... Read More
-
Asia-Pacific Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Leading Cystic Fibrosis Therapeutics Treatment Markets Databank
... 2021 to 2029. Route of Administration segment is expected to be the highest contributor to this market, with $2,818.1 Million in 2020, and is anticipated to reach $3,481.8 Million by 2029, registering a CAGR of ... Read More
-
USA Nasal Decolonization Market Insights, Forecast to 2028
... 105.76 million by the end of 2028, growing at a CAGR of 7.49% during 2022-2028. USA Nasal Decolonization Scope and Segment Nasal Decolonization market is segmented by type, and by application. Players, stakeholders, and other ... Read More
-
Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the ... Read More
-
Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Ventilator-associated pneumonia (VAP) is pneumonia that develops ... Read More
-
Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline landscape. Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a ... Read More
-
Acute Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Acute Respiratory Distress Syndrome (Respiratory) pipeline landscape. Acute respiratory distress syndrome (ARDS) occurs when fluid ... Read More
-
Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline landscape. Hospital Acquired Pneumonia (HAP) is defined as ... Read More
-
Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Cardiovascular Devices, Multi-Parameter ECG Monitors, Patient Monitoring Devices, Ambulatory Cardiac Monitoring, and Cardiac Monitors), Product Type (Portable Monitor, Smart Wearable Monitor, and Standard Monitor), Application (Coronary Heart Diseases, Sudden Cardiac Arrest, Stroke, Arrhythmia, Congenital Heart Diseases, Heart Failure, Pulmonary Hypertension, Heart Function (HF/LVEDP), Pulmonary Artery Pressure (PA), and Others), and End User (Hospitals, Ambulatory Surgery Centers, Cardiac Centers, Home Care, Clinics, and Others)
... Monitor, and Standard Monitor), Application (Coronary Heart Diseases, Sudden Cardiac Arrest, Stroke, Arrhythmia, Congenital Heart Diseases, Heart Failure, Pulmonary Hypertension, Heart Function (HF/LVEDP), Pulmonary Artery Pressure (PA), and Others), and End User (Hospitals, Ambulatory Surgery ... Read More
-
Global Dry Powder Inhaler Market Size study, by Product (Single Dose Dry Powder Inhalers, Multi Dose Dry Powder Inhalers) by Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Diabetes, Cystic Fibrosis) by Function (Manually operated Inhaler Devices, digitally operated Inhaler Devices) by end use industries (Institutional Sales, Retail Sales, Mail Order Pharmacies) and Regional Forecasts 2022-2028
... (Manually operated Inhaler Devices, digitally operated Inhaler Devices) by end use industries (Institutional Sales, Retail Sales, Mail Order Pharmacies) and Regional Forecasts 2022-2028Global Dry Powder Inhaler Market is valued approximately USD XX billion in 2021 ... Read More
-
2022 Global: In Vitro Lung Model - Innovative Markets Forecast (2028) report
... the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 ... Read More
-
Oxygen Long Term Covid Treatment Equipment: Market Shares, Strategies, and Forecasts, 2022 to 2028
... Forecasts, 2022 to 2028. The 2022 study has 198 pages, 93 tables and figures. Exercise intolerance is responsive to intermittent supplemental oxygen. Oxygen treatments represent next generation automation of helping people who are challenged by ... Read More
-
2022 Global Forecast for Respiratory Syncytial Virus (Rsv) Diagnostics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material ... Read More
-
2022 Global Forecast for Respiratory Care Devices (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Therapeutic Respiratory Devices Market
... more important market dynamics. After conducting thorough research on the historical and current growth parameters of the Therapeutic Respiratory Devices Market, the growth prospects of the market are obtained with maximum precision. Market Segmentation The ... Read More
-
Sleep Apnea Devices Market Size By Product (Therapeutics {Airway Clearance System, Adaptive Servo-ventilation {ASV}, Positive Airway Pressure {PAP} Device, Oral Appliances, Oxygen Devices}, Diagnostics {Actigraphy Systems, Polysomnography {PSG} Device, Respiratory Polygraph, Sleep Screening Devices}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The global sleep apnea devices ... Read More
-
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size study, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028
... Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is valued approximately USD ... Read More
-
Bronchopulmonary Dysplasia - Market Insight, Epidemiology And Market Forecast - 2032
... EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Bronchopulmonary Dysplasia market report provides current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted 7MM Bronchopulmonary Dysplasia market ... Read More
-
Cystic Fibrosis - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Cystic Fibrosis ... Read More
-
U.S. Hospice Market Size, Share & Trends Analysis Report By Location (Hospice Center, Home Hospice Care), By Type (RHC, CHC), By Diagnosis (Dementia, Cancer, Respiratory, Stroke), And Segment Forecasts, 2022 - 2030
... a CAGR of 8.20% over the forecast period. The rising healthcare expenditure, awareness about the benefits of palliative and end-of-life care, and favorable reimbursements are some of the major growth drivers. According to the NHPCO, ... Read More
-
Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline landscape. Nasopharyngitis also known as common cold is an infectious, ... Read More
-
Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Other Applications] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The global digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% ... Read More
-
Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The carbapenem-based antibiotics market size is projected to reach US$ 5,346.62 million by 2028 from US$ 3,964.57 million in 2021; it is estimated to ... Read More
-
Sleep Apnea Devices Market (Diagnostic Device: Actigraphy Systems, Polysomnography [PSG] Devices, Respiratory Polygraph, and Single-channel Screening Devices (Pulse Oximeters) and Therapeutic Device: Airway Clearance Systems, Adaptive Servo-ventilation [ASV], Positive Airway Pressure [PAP] Devices, Oral Appliances, Oxygen Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Oxygen Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Sleep Apnea Devices Market – Scope of Report TMR’s report on the global sleep apnea devices market studies past as ... Read More
Research Assistance
